These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estrogen receptor immunoreactivity in meningiomas. Comparison with the binding activity of estrogen, progesterone, and androgen receptors. Lesch KP; Gross S J Neurosurg; 1987 Aug; 67(2):237-43. PubMed ID: 3298569 [TBL] [Abstract][Full Text] [Related]
3. Correlation between estrophilin immunoreactivity and androgen receptor-binding activity in meningiomas. Lesch KP; Schott W; Engl HG; Gross S Eur Neurol; 1987; 26(4):252-7. PubMed ID: 3297710 [TBL] [Abstract][Full Text] [Related]
4. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity. Lesch KP; Engl HG; Schott W; Gross S Zentralbl Neurochir; 1987; 48(2):124-34. PubMed ID: 3314266 [TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]-methyltrienolone (R1881) by human breast cancers. Miller WR; Telford J; Hawkins RA Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1473-8. PubMed ID: 6605855 [TBL] [Abstract][Full Text] [Related]
6. Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands. Schwemmer B; Böttger I; Schiessl J; Reidel G; Schütz W Urol Int; 1986; 41(2):133-8. PubMed ID: 2425471 [TBL] [Abstract][Full Text] [Related]
7. Expression of androgen and progesterone receptors in primary human meningiomas. Maxwell M; Galanopoulos T; Neville-Golden J; Antoniades HN J Neurosurg; 1993 Mar; 78(3):456-62. PubMed ID: 8433149 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor assay with [3H]methyltrienolone (R1881) in the presence of progesterone receptors. Zava DT; Landrum B; Horwitz KB; McGuire WL Endocrinology; 1979 Apr; 104(4):1007-12. PubMed ID: 436741 [No Abstract] [Full Text] [Related]
9. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related]
15. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546 [No Abstract] [Full Text] [Related]
16. Simultaneous estradiol and progesterone receptor analysis in meningiomas. Lesch KP; Fahlbusch R Surg Neurol; 1986 Sep; 26(3):257-63. PubMed ID: 3738720 [TBL] [Abstract][Full Text] [Related]
17. Stabilization of androgen receptor by nonandrogenic steroids. Nemoto T; Ohara-Nemoto Y; Sato M; Ota M Biochem Int; 1986 May; 12(5):701-5. PubMed ID: 3488063 [TBL] [Abstract][Full Text] [Related]
18. Progesterone and glucocorticoid receptor activation in meningiomas. Carroll RS; Zhang J; Dashner K; Black PM Neurosurgery; 1995 Jul; 37(1):92-7. PubMed ID: 8587697 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor in human skin cytosol. Mowszowicz I; Riahi M; Wright F; Bouchard P; Kuttenn F; Mauvais-Jarvis P J Clin Endocrinol Metab; 1981 Feb; 52(2):338-44. PubMed ID: 6970202 [TBL] [Abstract][Full Text] [Related]
20. Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH). Asselin J; Labrie F; Gourdeau Y; Bonne C; Raynaud JP Steroids; 1976 Oct; 28(4):449-59. PubMed ID: 64005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]